The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 trial of claudin 18.2-specific antibody-drug conjugate CMG901 in patients with advanced gastric/gastroesophageal junction cancer.
 
Rui-Hua Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; HenRui; Junshi Biosciences; KYM Biosciences; Merck Serono; Roche
 
Dan-Yun Ruan
Consulting or Advisory Role - KYM Biosciences
 
Dong-Sheng Zhang
Consulting or Advisory Role - KYM Biosciences
 
Fu-Rong Liu
Employment - Simcere
 
Su-Xia Luo
Consulting or Advisory Role - KYM Biosciences
 
Zhi-Xiang Zhuang
Consulting or Advisory Role - KYM Biosciences
 
Zhen-Ning Wang
Consulting or Advisory Role - KYM Biosciences
 
Fu-Nan Liu
Consulting or Advisory Role - KYM Biosciences
 
Yan-Qiao Zhang
Consulting or Advisory Role - KYM Biosciences
 
Jian-Wei Yang
No Relationships to Disclose
 
Zhen-Dong Chen
Consulting or Advisory Role - KYM Biosciences
 
Yong-Sheng Wang
Consulting or Advisory Role - KYM Biosciences
 
Jun-Ye Wang
Consulting or Advisory Role - KYM Biosciences
 
Xiao-Hua Liang
Consulting or Advisory Role - KYM Biosciences
 
Xiao-Jie Wu
Consulting or Advisory Role - KYM Biosciences
 
Yu-Long Zheng
Consulting or Advisory Role - KYM Biosciences
 
Jian Liu
Consulting or Advisory Role - KYM Biosciences
 
Xi Shi
Consulting or Advisory Role - KYM Biosciences
 
Wei Liu
Employment - KYM Biosciences
Leadership - KYM Biosciences
 
Bo Chen
Employment - KYM Biosciences
Leadership - KYM Biosciences
Stock and Other Ownership Interests - KYM Biosciences